Both in Pharmaceuticals
Spero Therapeutics vs Rani Therapeutics Holdings
Over the past year SPRO returned −50.8% and RANI returned −67.4%; their daily moves had a correlation of 0.13.
SPRO −50.8% RANI −67.4%Growth of $1, one year, split-adjusted
| Metric | SPRO | RANI |
|---|---|---|
| Price | $1.17 | $0.6153 |
| Market cap | $68.1M | $71.0M |
| Today | +2.63% | +0.98% |
| 1 month | −2.5% | −23.1% |
| 6 months | −53.8% | −29.6% |
| Year to date | −49.8% | −54.4% |
| 1 year | −48.9% | −65.4% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | 100.0% |
| Net margin | — | −432.7% |
| P/E (TTM) | 9.2× | — |
| Price / sales | 1.4× | 14.6× |
| Net cash | $50.7M | $53.4M |
| Dividend yield | — | — |
| Volatility (60d) | 57.4% | 62.6% |
| Short % of float | 2.0% | 10.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).